99 related articles for article (PubMed ID: 7809890)
1. [Tumor marker analyses--valuable tools if used correctly].
Børmer OP; Paus E; Nustad K; Theodorsen L
Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3317-20. PubMed ID: 7809890
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers (advances and limits)].
Gomes FR
Acta Med Port; 1997 Jan; 10(1):75-80. PubMed ID: 9245182
[TBL] [Abstract][Full Text] [Related]
3. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract][Full Text] [Related]
4. [What are tumor markers, and what is their value?].
von Kleist S
Wien Klin Wochenschr; 1989 Jul; 101(14):459-63. PubMed ID: 2672605
[TBL] [Abstract][Full Text] [Related]
5. Human tetranectin: methodological and clinical studies.
Høgdall CK
APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
[TBL] [Abstract][Full Text] [Related]
6. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
7. [Histopathology and tumor markers].
Kijima H; Ueyama Y; Osamura Y
Rinsho Byori; 2003 Dec; 51(12):1203-15. PubMed ID: 14743744
[TBL] [Abstract][Full Text] [Related]
8. Tumour marker measurements in the diagnosis and monitoring of breast cancer.
Cheung KL; Graves CR; Robertson JF
Cancer Treat Rev; 2000 Apr; 26(2):91-102. PubMed ID: 10772967
[TBL] [Abstract][Full Text] [Related]
9. [Future prospects for the use of tumor markers].
Grunicke H
Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
[TBL] [Abstract][Full Text] [Related]
12. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
13. Tumour marker prescriptions for cancer screening in the Hellenic primary care.
Vittoraki A; Alexiou G; Karakatsanis A; Mauri D; Xilomenos A; Zacharias G; Koukourakis G; Hrysovalantou-Marsoni E; Milousis A; Athanasiadou M; Chasioti D
Eur J Cancer Care (Engl); 2007 Jan; 16(1):86-9. PubMed ID: 17227357
[TBL] [Abstract][Full Text] [Related]
14. Serum tumour markers in clinical practice. Some general aspects.
Kvinnsland S
Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761
[TBL] [Abstract][Full Text] [Related]
15. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
16. [Role of tumour markers in monitoring and follow-up of colorectal cancer patients].
Beczássy E; Ottó S; Vámosi Nagy I
Magy Onkol; 2004; 48(1):57-61. PubMed ID: 15105897
[TBL] [Abstract][Full Text] [Related]
17. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Gebauer G; Müller-Ruchholtz W
Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569
[TBL] [Abstract][Full Text] [Related]
18. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
